Skip to main content

Contact Lens Solutions

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Bausch + Lomb
Bausch + LombNJ - Bridgewater
2 programs
Bausch & Lomb Multi-Purpose SolutionN/A
Bausch & Lomb Multipurpose Solution - Rub CareN/A
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
2 programs
Bausch & Lomb Multi-Purpose SolutionN/A1 trial
Bausch & Lomb Multipurpose Solution - Rub CareN/A1 trial
Active Trials
NCT00710879Completed180Est. Feb 2009
NCT00636363Completed541Est. Aug 2008

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Bausch HealthBausch & Lomb Multi-Purpose Solution
Bausch HealthBausch & Lomb Multipurpose Solution - Rub Care

Clinical Trials (2)

Total enrollment: 721 patients across 2 trials

NCT00710879Bausch HealthBausch & Lomb Multi-Purpose Solution

Evaluation of a Multi-Purpose Solution

Start: Jul 2008Est. completion: Feb 2009180 patients
N/ACompleted
NCT00636363Bausch HealthBausch & Lomb Multipurpose Solution - Rub Care

Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution

Start: Mar 2008Est. completion: Aug 2008541 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.